Talis Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MENLO PARK, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care (the “Company”), announced that the Company’s Board of...

Click to view original post